Crystal Adam Insider Trading -- Recent SEC Form 4 Transactions
Crystal Adam (CIK 1825445) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-05). Recent activity: Buy TNGX (27,000 shares), Sell TNGX (26,400 shares), Sell TNGX (600 shares), Buy TNGX (27,000 shares), Sell TNGX (27,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-10-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 26,400 | $645,604 |
| 2026-10-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 600 | $15,192 |
| 2026-09-03 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-09-03 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 27,000 | $603,909 |
| 2026-08-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 5,267 | $141,100 |
| 2026-08-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-08-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 21,733 | $594,417 |
| 2026-07-02 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-07-02 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 19,629 | $575,962 |
| 2026-07-02 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 7,371 | $222,946 |
| 2026-06-03 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-06-03 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 20,860 | $481,032 |
| 2026-06-03 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 6,140 | $136,615 |
| 2026-05-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-05-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 25,900 | $548,821 |
| 2026-05-05 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 1,100 | $24,200 |
| 2026-04-16 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 38,460 | $199,992 |
| 2026-04-16 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 38,460 | $961,500 |
| 2026-04-02 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 27,000 | $140,400 |
| 2026-04-02 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 27,000 | $572,400 |
| 2026-03-27 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Buy | 12,000 | $62,400 |
| 2026-03-27 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 12,000 | $241,320 |
| 2026-03-09 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 20,251 | $303,765 |
| 2026-02-27 | Tango Therapeutics, Inc. (TNGX) | President, R&D | Sell | 54,345 | $693,986 |
Source: SEC Form 4 filings · as of 2026-10-05